跳至主要内容
临床试验/NCT05338021
NCT05338021已完成不适用

Serum and Wound Vancomycin Levels Following Intrawound Administration in Primary Total Knee Arthroplasty

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年5月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Intra-articular vancomycin concentration

研究概览

简要总结

The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total knee arthroplasty.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age between 50 and 80
  • •Total knee arthroplasty for primary osteoarthritis. Primary diagnosis of knee osteoarthritis

排除标准

  • •Diminished mental capacity
  • •Vancomycin allergy
  • •Chronic kidney disease stage III and stage IV

研究组 & 干预措施

Intrawound Administration of Vancomycin

Experimental

After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 20ml of normal saline was injected directly into the joint.

干预措施: Intrawound administration of vancomycin after closure of the arthrotomy (Procedure)

Intrawound Administration of Vancomycin combined with epsilon-aminocaproic acid (EACA)

Experimental

After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 4g (20ml) of epsilon-aminocaproic acid (EACA) was injected directly into the joint.

干预措施: Intrawound administration of vancomycin after closure of the arthrotomy (Procedure)

结局指标

主要结局

Intra-articular vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

Serum vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

Renal function

时间窗: Postoperative Day 1 and Day 3

blood urea nitrogen (BUN), creatinine (Cr), GFR

Blood loss

时间窗: Postoperative Day 3

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiang Shuai, MD

Principal Investigator

The Affiliated Hospital of Qingdao University

研究点 (1)

Loading locations...

相似试验